Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders. 

Biotechnology

Alexion Pharmaceuticals

Alexion Pharmaceuticals' headquarters in New Haven, CT, United States

Marc Dunoyer

Julio Hasquiry

Andrea Passalacqua

Fred Chereau

Scott Weintraub

Leticia Beleta

Keith Woods

Cho Yoonjoo

Jonathan Lu

N.r. Sumathi

Sarah Marshall

Soraya Bekkali

Sean Christie

Felix J. Baker

Christopher J. Coughlin

Andreas Rummelt

Judith A. Reinsdorf

Paul A. Friedman

David R. Brennan

John T. Mollen

The Clinical Development and Medical Affairs team at Alexion Pharmaceuticals is responsible for the strategic planning and execution of clinical trials to evaluate new biologic therapies for life-threatening diseases. This team collaborates closely with researchers, regulatory bodies, and healthcare professionals to ensure robust data collection, patient safety, and compliance with regulatory standards while driving scientific innovation and advancing product development. Additionally, they play a pivotal role in disseminating clinical findings and supporting medical education initiatives to inform healthcare providers about the therapeutic benefits of their products.

Clinical Development and Medical Affairs

The Global Commercial Strategy and Operations team at Alexion Pharmaceuticals focuses on developing and executing strategic initiatives to optimize the commercialization of innovative therapies for rare diseases. This team collaborates across various functions, including sales, marketing, and talent acquisition, to drive operational excellence, enhance customer engagement, and ensure the effective training and development of sales personnel. Their efforts are aimed at maximizing market impact and improving patient access to life-saving treatments.

Global Commercial Strategy and Operations

The Leadership Team at Alexion Pharmaceuticals is responsible for setting the strategic direction of the company, overseeing operational execution across various departments, and ensuring alignment with the mission to develop and deliver life-saving therapies. Comprising top executives from global supply chain, finance, compliance, research, and corporate affairs, the team collaborates to drive innovation, optimize resource allocation, and maintain regulatory standards while fostering a culture of accountability and growth within the organization.

Leadership Team

Alexion Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Development and Medical Affairs

Global Commercial Strategy and Operations

Leadership Team

Offices

Alexion Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Development and Medical Affairs

Global Commercial Strategy and Operations

Leadership Team

Offices

Related companies